Fundies.
English

Kezar Life Sciences, Inc.

EDGAR
KZR Quarterly report (10-Q) · filed 2026-05-11

Annual consolidated revenue for 2025: about USD 0, using the latest reported figures. The previous period, 2024, was about USD 0.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

0 USD

2024 Q4 · USD

Exact inputs and evidence

Operating cash flow

-16.8 million USD

2024 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -74212000 USD Source
  • Operating Cash Flow: -57387000 USD Source

Free cash flow

-16.8 million USD

2024 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -74212000 USD Source
  • Operating Cash Flow: -57387000 USD Source
  • Capital Expenditure: 29000 USD Source
  • Capital Expenditure: 18000 USD Source
Cash and cash equivalents
66.2 million USD Source
Exact value

66229000 USD

Long-term debt including current maturities
10.3 million USD Source
Exact value

10262000 USD

Shares outstanding
7.37 million shares Source
Exact value

7374375 shares

Reported share-count change

0.94% · 68.6 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 7305800 shares · 2025-03-31· Source
  • 7374375 shares · 2026-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-45.2 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Net income: -13704000 USD · 2025-04-01 – 2025-06-30 Source
  • Net income: -11227000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -56033000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -41487000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -5756000 USD · 2026-01-01 – 2026-03-31 Source

Operating cash flow

-42 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Operating cash flow: -29985000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -17190000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -39815000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -29985000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -51777000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -39815000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -7445000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

0 USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-42 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence
  • Operating cash flow: -29985000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -17190000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -39815000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -29985000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -51777000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -39815000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -7445000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 8000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-05-11.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 5 of 11 periods available· newest 2025-12-31
  • Operating income: 10 of 11 periods available· newest 2025-12-31
  • Net income: 10 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 10 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 10 of 11 periods available· newest 2025-12-31
  • Total assets: 5 of 11 periods available· newest 2025-12-31
  • Total liabilities: 5 of 11 periods available· newest 2025-12-31
  • Current assets: 5 of 11 periods available· newest 2025-12-31
  • Current liabilities: 5 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 5 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 3 of 11 periods available· newest 2023-12-31
  • Shares outstanding: 5 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    USD 0

    Prior period

    USD 0

    –

    Current period

    USD 0

    –

    Exact inputs and evidence

    0 − 0 = 0 USD

    0 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    0 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 27.7 million

    Prior period

    −USD 83.74 million

    –

    Current period

    −USD 56.03 million

    –

    Exact inputs and evidence

    -56033000 − -83736000 = 27703000 USD

    -83736000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -56033000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 22.44 million

    Prior period

    −USD 74.21 million

    –

    Current period

    −USD 51.78 million

    –

    Exact inputs and evidence

    -51777000 − -74212000 = 22435000 USD

    -74212000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -51777000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -72.4%

    Prior period

    USD 29,000

    –

    Current period

    USD 8,000

    –

    Exact inputs and evidence

    8000 − 29000 = -21000 USD

    29000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    8000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 0
  • Operating costs Derived USD 59.11 million
  • Operating income −USD 59.11 million
  • Tax, interest and other Derived −USD 3.07 million
  • Net income −USD 56.03 million

Cash

  • Operating cash flow −USD 51.78 million
  • Capital expenditure USD 8,000
  • Free cash flow Derived −USD 51.79 million

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Not shown: operating income or net income is not reported.
  • 2022 Not shown: operating income or net income is not reported.
  • 2023 Operating loss: operating costs were 1,692% of revenue.
  • 2024 Not shown: operating income or net income is not reported.
  • 2025 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-310 54659000 Derived -54659000 -29000 Derived -54630000 -42753000 Derived
Source
2022 2022-01-01 – 2022-12-310 71162000 Derived -71162000 -2923000 Derived -68239000 -60424000 Derived
Source
2023 2023-01-01 – 2023-12-317000000 118424000 Derived -111424000 -9554000 Derived -101870000 -83455000 Derived
Source
2024 2024-01-01 – 2024-12-310 90605000 Derived -90605000 -6869000 Derived -83736000 -74241000 Derived
Source
2025 2025-01-01 – 2025-12-310 59107000 Derived -59107000 -3074000 Derived -56033000 -51785000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.6M5.7M3.8M1.9M0.020212022202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Revenue0
2022Revenue0
2023Revenue7000000
2024Revenue0
2025Revenue0

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2024
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8%-21%-50%-79%-108%20212022202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over yearNo prior comparable period
2023Year over yearNo prior comparable period
2024Year over year-100%
2025Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,591.8% 2023
Net margin -1,455.3% 2023
Free cash flow margin -1,192.2% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.127%-334%-796%-1,257%-1,719%20212022202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021Operating marginNot reported
2022Operating marginNot reported
2023Operating margin-1,591.8%
2024Operating marginNot reported
2025Operating marginNot reported
2021Net marginNot reported
2022Net marginNot reported
2023Net margin-1,455.3%
2024Net marginNot reported
2025Net marginNot reported
2021Free cash flow marginNot reported
2022Free cash flow marginNot reported
2023Free cash flow margin-1,192.2%
2024Free cash flow marginNot reported
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -51.8M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6.5M-17.1M-40.8M-64.5M-88.2M20212022202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Operating cash flow-42437000
2022Operating cash flow-58846000
2023Operating cash flow-81645000
2024Operating cash flow-74212000
2025Operating cash flow-51777000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -51.8M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6.7M-17.5M-41.7M-65.9M-90.1M20212022202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Free cash flow-42753000
2022Free cash flow-60424000
2023Free cash flow-83455000
2024Free cash flow-74241000
2025Free cash flow-51785000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

8.6% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.20.7%15.5%10.4%5.2%0.0%20212022202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021Liabilities / assets9.7%
2022Liabilities / assets9.9%
2023Liabilities / assets15.2%
2024Liabilities / assets19.2%
2025Liabilities / assets8.6%

Current assets to current liabilities

Current assets divided by current liabilities.

11.52× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.28.06×21.05×14.03×7.02×0.00×20212022202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021Current assets / current liabilities25.77×
2022Current assets / current liabilities25.98×
2023Current assets / current liabilities11.66×
2024Current assets / current liabilities6.76×
2025Current assets / current liabilities11.52×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 8.99 million
Exact value

Exact value: -8990000 USD

2016-01-01 – 2016-12-31: -8990000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.76 million
Exact value

Exact value: -9760000 USD

2016-01-01 – 2016-12-31: -9760000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 132,000
Exact value

Exact value: 132000 USD

2016-01-01 – 2016-12-31: 132000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.89 million
Calculation and evidence

-9760000 − 132000 USD

Exact free cash flow: -9892000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 8.52 million
Exact value

Exact value: -8517000 USD

2017-01-01 – 2017-12-31: -8517000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.11 million
Exact value

Exact value: -8109000 USD

2017-01-01 – 2017-12-31: -8109000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 389,000
Exact value

Exact value: 389000 USD

2017-01-01 – 2017-12-31: 389000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.5 million
Calculation and evidence

-8109000 − 389000 USD

Exact free cash flow: -8498000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 23.17 million
Exact value

Exact value: -23167000 USD

2018-01-01 – 2018-12-31: -23167000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 20.79 million
Exact value

Exact value: -20792000 USD

2018-01-01 – 2018-12-31: -20792000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.12 million
Exact value

Exact value: 1120000 USD

2018-01-01 – 2018-12-31: 1120000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.91 million
Calculation and evidence

-20792000 − 1120000 USD

Exact free cash flow: -21912000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 35.09 million
Exact value

Exact value: -35087000 USD

2019-01-01 – 2019-12-31: -35087000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 29.88 million
Exact value

Exact value: -29877000 USD

2019-01-01 – 2019-12-31: -29877000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 607,000
Exact value

Exact value: 607000 USD

2019-01-01 – 2019-12-31: 607000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30.48 million
Calculation and evidence

-29877000 − 607000 USD

Exact free cash flow: -30484000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 41.74 million
Exact value

Exact value: -41742000 USD

2020-01-01 – 2020-12-31: -41742000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 36.95 million
Exact value

Exact value: -36949000 USD

2020-01-01 – 2020-12-31: -36949000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 194,000
Exact value

Exact value: 194000 USD

2020-01-01 – 2020-12-31: 194000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 37.14 million
Calculation and evidence

-36949000 − 194000 USD

Exact free cash flow: -37143000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 54.63 million
Exact value

Exact value: -54630000 USD

2021-01-01 – 2021-12-31: -54630000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 42.44 million
Exact value

Exact value: -42437000 USD

2021-01-01 – 2021-12-31: -42437000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 316,000
Exact value

Exact value: 316000 USD

2021-01-01 – 2021-12-31: 316000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 42.75 million
Calculation and evidence

-42437000 − 316000 USD

Exact free cash flow: -42753000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 68.24 million
Exact value

Exact value: -68239000 USD

2022-01-01 – 2022-12-31: -68239000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 58.85 million
Exact value

Exact value: -58846000 USD

2022-01-01 – 2022-12-31: -58846000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.58 million
Exact value

Exact value: 1578000 USD

2022-01-01 – 2022-12-31: 1578000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 60.42 million
Calculation and evidence

-58846000 − 1578000 USD

Exact free cash flow: -60424000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 101.87 million
Exact value

Exact value: -101870000 USD

2023-01-01 – 2023-12-31: -101870000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 81.65 million
Exact value

Exact value: -81645000 USD

2023-01-01 – 2023-12-31: -81645000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.81 million
Exact value

Exact value: 1810000 USD

2023-01-01 – 2023-12-31: 1810000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 83.46 million
Calculation and evidence

-81645000 − 1810000 USD

Exact free cash flow: -83455000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 83.74 million
Exact value

Exact value: -83736000 USD

2024-01-01 – 2024-12-31: -83736000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 74.21 million
Exact value

Exact value: -74212000 USD

2024-01-01 – 2024-12-31: -74212000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 29,000
Exact value

Exact value: 29000 USD

2024-01-01 – 2024-12-31: 29000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 74.24 million
Calculation and evidence

-74212000 − 29000 USD

Exact free cash flow: -74241000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 56.03 million
Exact value

Exact value: -56033000 USD

2025-01-01 – 2025-12-31: -56033000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 51.78 million
Exact value

Exact value: -51777000 USD

2025-01-01 – 2025-12-31: -51777000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 8,000
Exact value

Exact value: 8000 USD

2025-01-01 – 2025-12-31: 8000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 51.79 million
Calculation and evidence

-51777000 − 8000 USD

Exact free cash flow: -51785000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

60 filings · 2,037 latest values · 2,037 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001645666, 1645666, KZR, edgar:1645666

Also known as Kezar Life Sciences, Inc.